Page last updated: 2024-09-03

3,3'-dipropyl-2,2'-thiadicarbocyanine and Autoimmune Diabetes

3,3'-dipropyl-2,2'-thiadicarbocyanine has been researched along with Autoimmune Diabetes in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cheong, LY; Hoo, RL; Liao, B; Liu, Y; Shu, L; Wu, X; Xiao, X; Xiao, Y; Xu, A; Zhou, Z1
Bryszewska, M; Cársky, J; R kawiecka, K; Sikurová, L; Ulicná, O; Waczulíková, I1

Other Studies

2 other study(ies) available for 3,3'-dipropyl-2,2'-thiadicarbocyanine and Autoimmune Diabetes

ArticleYear
Fatty acid binding protein 4 promotes autoimmune diabetes by recruitment and activation of pancreatic islet macrophages.
    JCI insight, 2021, 04-08, Volume: 6, Issue:7

    Topics: Adult; Animals; Autoantibodies; Benzothiazoles; Bone Marrow Transplantation; Carbocyanines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Fatty Acid-Binding Proteins; Female; Humans; Islets of Langerhans; Macrophages; Male; Mice, Inbred NOD; Mice, Mutant Strains; Middle Aged; T-Lymphocytes

2021
Impaired erythrocyte transmembrane potential in diabetes mellitus and its possible improvement by resorcylidene aminoguanidine.
    Bioelectrochemistry (Amsterdam, Netherlands), 2000, Volume: 52, Issue:2

    Topics: Benzothiazoles; Carbocyanines; Diabetes Mellitus, Type 1; Erythrocyte Membrane; Fluorescent Dyes; Guanidines; Humans; Membrane Potentials

2000